AKYNZEO is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Helsinn Therapeutics (u.s.), Inc.. The primary component is Fosnetupitant; Palonosetron Hydrochloride.
| Product ID | 69639-102_13e49207-5307-4add-ab8d-a5bdc8138704 |
| NDC | 69639-102 |
| Product Type | Human Prescription Drug |
| Proprietary Name | AKYNZEO |
| Generic Name | Fosnetupitant And Palonosetron |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2018-04-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA210493 |
| Labeler Name | Helsinn Therapeutics (U.S.), Inc. |
| Substance Name | FOSNETUPITANT; PALONOSETRON HYDROCHLORIDE |
| Active Ingredient Strength | 260 mg/1; mg/1 |
| Pharm Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2018-04-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA210493 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-04-20 |
| Ingredient | Strength |
|---|---|
| FOSNETUPITANT | 260 mg/1 |
| SPL SET ID: | 8e47618e-af46-4d82-94e8-1507c042252d |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 69639-101 | AKYNZEO | Netupitant and Palonosetron |
| 69639-102 | AKYNZEO | Fosnetupitant and Palonosetron |
| 69639-105 | AKYNZEO | Fosnetupitant and Palonosetron |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() AKYNZEO 85264083 4066299 Live/Registered |
Helsinn Healthcare S.A. 2011-03-11 |
![]() AKYNZEO 79140820 4595036 Live/Registered |
Helsinn Healthcare SA 2013-10-17 |